CN105853504B - Anti-tumor beverage - Google Patents

Anti-tumor beverage Download PDF

Info

Publication number
CN105853504B
CN105853504B CN201610203955.6A CN201610203955A CN105853504B CN 105853504 B CN105853504 B CN 105853504B CN 201610203955 A CN201610203955 A CN 201610203955A CN 105853504 B CN105853504 B CN 105853504B
Authority
CN
China
Prior art keywords
parts
powder
tumor
beverage
mixing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610203955.6A
Other languages
Chinese (zh)
Other versions
CN105853504A (en
Inventor
叶善中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610203955.6A priority Critical patent/CN105853504B/en
Publication of CN105853504A publication Critical patent/CN105853504A/en
Application granted granted Critical
Publication of CN105853504B publication Critical patent/CN105853504B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/583—Snakes; Lizards, e.g. chameleons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/41—Crassulaceae (Stonecrop family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00—Preparation of other alcoholic beverages
    • C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Abstract

An anti-tumor beverage is prepared by mixing the following raw material medicines in parts by weight: 5-10 parts of Chinese yew leaf powder, 6-9 parts of angelica powder, 10-30 parts of toad venom, 20-40 parts of hulled flaxseed powder, 10-30 parts of snake gall, 10-20 parts of scorpion, 2-5 parts of rhodiola root powder and 60-120 parts of alcohol.

Description

Anti-tumor beverage
Technical Field
The invention relates to the field of nutritional health products, in particular to an anti-tumor beverage.
Background
In the prior art, tumors are the result of abnormal growth and proliferation of cells in the human body. When normal cells are mutated or changed to become tumor cells, the human body has problems and suffers from tumor diseases. Some tumor cells do not invade adjacent tissues or disseminate with blood to other sites, which is called benign tumor, is generally not life-threatening, and can be cured by surgical excision or by taking medicine. If tumor cells damage surrounding normal cells and invade other parts of the body through blood circulation, they are called malignant tumors, which we generally say cancer. The greatest threat to malignancy is its ability to metastasize to various parts of the body, gradually, as the tumor expands, normal cells die, organ failure eventually leading to patient death. At present, a plurality of methods for treating tumors exist, and the common tumors are generally treated by adopting operations and medicines, so that the tumor treatment cost is high, and the tumors are easy to relapse; the malignant tumor is treated by chemotherapy, radiotherapy, surgical excision, traditional Chinese medicine and the like; the method can cure malignant tumors of certain parts, such as breast cancer, with high cure rate by adopting chemotherapy, radiotherapy and surgical excision, but has low cure rate for tumors of other parts, so that the side effects of the chemotherapy and the radiotherapy are large, the treatment cost is high, many patients are difficult to accept, and the traditional Chinese medicine method for treating the cancers is many, but most of the traditional Chinese medicine methods have high cost, poor anti-tumor effect and easy recurrence.
Disclosure of Invention
The invention aims to provide an anti-tumor beverage and a medicament for treating tumors and cancers with better curative effect.
The invention discloses an anti-tumor beverage which is prepared by mixing the following raw material medicines in parts by weight:
5-10 parts of Chinese yew leaf powder, 6-9 parts of angelica powder, 10-30 parts of toad venom, 20-40 parts of hulled flaxseed powder, 10-30 parts of snake gall, 10-20 parts of scorpion, 2-5 parts of rhodiola root powder and 60-120 parts of alcohol.
Furthermore, the anti-tumor beverage also comprises 10-13 parts by weight of honey.
Furthermore, the anti-tumor beverage also comprises dogwood in 4-12 parts by weight.
Furthermore, the anti-tumor beverage also comprises 3-5 parts by weight of angelica.
The invention also discloses a preparation method of the anti-tumor beverage, which comprises the following steps:
mixing fel Serpentis with equal amount of ethanol, and pulverizing into slurry;
mixing Scorpio with equal amount of ethanol, and pulverizing into slurry;
mixing the two slurry liquids, mixing with folium taxi Cuspidatae powder, radix Angelicae sinensis powder, Bufonis venenum, shelled semen Lini powder, and radix Rhodiolae powder, and stirring; adding alcohol into the uniformly stirred mixed solution according to the required amount of the formula, and stirring again;
standing for 10-15 days in the absence of air, and taking out clear liquid after layering to obtain the anti-tumor beverage; filtering the turbid liquid, drying at low temperature, and grinding to form the byproduct anti-tumor powder.
The invention has the advantages of simple components, low cost, simple and convenient preparation method, no waste discharge in the preparation process and good curative effect.
Detailed Description
The following embodiments of the present invention will be further described with reference to the drawings and examples, which are only used to more clearly illustrate the technical solutions of the present invention, and should not be taken as limiting the scope of the present invention.
Example 1
The specific technical scheme of the invention is as follows:
the invention discloses an anti-tumor beverage which is prepared by mixing the following raw material medicines in parts by weight:
15 parts of toad venom, 33 parts of hulled flaxseed powder, 24 parts of snake gall, 16 parts of scorpion, 4 parts of rhodiola root powder and 110 parts of alcohol.
The invention also discloses a preparation method of the anti-tumor beverage, which comprises the following steps:
mixing fel Serpentis with equal amount of ethanol, and pulverizing into slurry;
mixing Scorpio with equal amount of ethanol, and pulverizing into slurry;
mixing the two slurry liquids, mixing with Bufonis venenum, shelled semen Lini powder, and radix Rhodiolae powder, and stirring; adding alcohol into the uniformly stirred mixed solution according to the required amount of the formula, and stirring again;
standing for 10-15 days in the absence of air, and taking out clear liquid after layering to obtain the anti-tumor beverage; filtering the turbid liquid, drying at low temperature, and grinding to form the byproduct anti-tumor powder.
The effect of the medicine after being taken by patients
Figure GDA0002276769700000031
Example 2
The invention discloses an anti-tumor beverage which is prepared by mixing the following raw material medicines in parts by weight:
5 parts of Chinese yew leaf powder, 6 parts of angelica powder, 10 parts of toad venom, 20 parts of hulled flaxseed powder, 10 parts of snake gall, 10 parts of scorpion, 2 parts of rhodiola root powder and 60 parts of alcohol.
The invention also discloses a preparation method of the anti-tumor beverage, which comprises the following steps:
mixing fel Serpentis with equal amount of ethanol, and pulverizing into slurry;
mixing Scorpio with equal amount of ethanol, and pulverizing into slurry;
mixing the two slurry liquids, mixing with folium taxi Cuspidatae powder, radix Angelicae sinensis powder, Bufonis venenum, shelled semen Lini powder, and radix Rhodiolae powder, and stirring; adding alcohol into the uniformly stirred mixed solution according to the required amount of the formula, and stirring again;
standing for 10-15 days in the absence of air, and taking out clear liquid after layering to obtain the anti-tumor beverage; filtering the turbid liquid, drying at low temperature, and grinding to form the byproduct anti-tumor powder.
Example 3
The invention discloses an anti-tumor beverage which is prepared by mixing the following raw material medicines in parts by weight:
10 parts of Chinese yew leaf powder, 9 parts of angelica powder, 30 parts of toad venom, 40 parts of hulled flaxseed powder, 30 parts of snake gall, 20 parts of scorpion, 5 parts of rhodiola root powder, 120 parts of alcohol and 13 parts of honey.
The invention also discloses a preparation method of the anti-tumor beverage, which comprises the following steps:
mixing fel Serpentis with equal amount of ethanol, and pulverizing into slurry;
mixing Scorpio with equal amount of ethanol, and pulverizing into slurry;
mixing the two slurry liquids, mixing with folium taxi Cuspidatae powder, radix Angelicae sinensis powder, Bufonis venenum, shelled semen Lini powder, and radix Rhodiolae powder, and stirring; adding alcohol into the uniformly stirred mixed solution according to the required amount of the formula, and stirring again;
standing for 10-15 days in the absence of air, and taking out clear liquid after layering to obtain the anti-tumor beverage; filtering the turbid liquid, drying at low temperature, and grinding to form the byproduct anti-tumor powder.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the technical principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.

Claims (1)

1. The anti-tumor beverage is characterized by being prepared by mixing the following raw material medicines in parts by weight:
5-10 parts of Chinese yew leaf powder, 6-9 parts of angelica powder, 10-30 parts of toad venom, 20-40 parts of hulled flaxseed powder, 10-30 parts of snake gall, 10-20 parts of scorpion, 2-5 parts of rhodiola powder and 60-120 parts of alcohol;
also comprises 10 to 13 weight portions of honey;
also comprises dogwood 4-12 parts by weight.
CN201610203955.6A 2016-04-01 2016-04-01 Anti-tumor beverage Active CN105853504B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610203955.6A CN105853504B (en) 2016-04-01 2016-04-01 Anti-tumor beverage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610203955.6A CN105853504B (en) 2016-04-01 2016-04-01 Anti-tumor beverage

Publications (2)

Publication Number Publication Date
CN105853504A CN105853504A (en) 2016-08-17
CN105853504B true CN105853504B (en) 2020-01-21

Family

ID=56627661

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610203955.6A Active CN105853504B (en) 2016-04-01 2016-04-01 Anti-tumor beverage

Country Status (1)

Country Link
CN (1) CN105853504B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106511414B (en) * 2016-12-13 2020-04-10 长春雷允上药业有限公司 Pharmaceutical composition for treating tumors, preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1876061A (en) * 2006-04-13 2006-12-13 张永顺 A medicine for treating hepatitis
CN101449838A (en) * 2007-12-06 2009-06-10 冷博 Flax-seed instant food
CN102488208A (en) * 2011-12-16 2012-06-13 江南大学 Preparation method for taxus healthcare cream
CN105395988A (en) * 2015-12-03 2016-03-16 河北大学 Antitumor oral liquid and preparation method thereof
CN105663698A (en) * 2014-11-20 2016-06-15 丛日艳 Preparation method of traditional Chinese medicine for treating tumors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1876061A (en) * 2006-04-13 2006-12-13 张永顺 A medicine for treating hepatitis
CN101449838A (en) * 2007-12-06 2009-06-10 冷博 Flax-seed instant food
CN102488208A (en) * 2011-12-16 2012-06-13 江南大学 Preparation method for taxus healthcare cream
CN105663698A (en) * 2014-11-20 2016-06-15 丛日艳 Preparation method of traditional Chinese medicine for treating tumors
CN105395988A (en) * 2015-12-03 2016-03-16 河北大学 Antitumor oral liquid and preparation method thereof

Also Published As

Publication number Publication date
CN105853504A (en) 2016-08-17

Similar Documents

Publication Publication Date Title
CN102302737B (en) Traditional Chinese medicine composition for treating gastric cancer
CN103571704A (en) Preparation method of agilawood health-care wine and agilawood wine thereof
Sun The role of Chinese medicine in clinical oncology
CN101671319B (en) Taxus nontoxic extract process
CN1772262A (en) Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process
CN105853504B (en) Anti-tumor beverage
CN105664140A (en) Glycopeptide composition as well as preparation method and application thereof
CN102688317A (en) Traditional Chinese medicine for treating liver cancer
CN106177790A (en) A kind of capsule treating tumor and preparation method thereof
CN1895337A (en) Pharmaceutical use of Tangshen and Milkvetch root composition for improving late tumor patient life quality
CN104707047A (en) External medicine for treating lung cancer and preparation method thereof
CN112915189A (en) Traditional Chinese medicine composition for inhibiting tumor and preparation method and application thereof
CN105194392A (en) Pharmaceutical composition for preventing and treating tumors
CN105267793B (en) A kind of new application of Chinese medicine composition
CN100556448C (en) Chinese medicine pharmaceutical composition of a kind of inhibition and treatment tumor and its production and application
CN104800737B (en) A kind of Chinese medicine composition for treating lymthoma
CN101439050B (en) Medicament for treating malignancy and production method
CN103655822B (en) Anti-tumor drug as well as preparation method and application thereof
CN107970372A (en) A kind of medicine for treating polytype tumour
CN102670863A (en) Compound propolis composition for treating acariasis of domestic animal and preparation method thereof
CN106620201A (en) Medicinal wine for treating breast diseases
CN101829193A (en) Medicine composite for treating cervical erosion and preparation method thereof
CN101406539A (en) Medicament for treating thrombocytopenia after chemotherapy
Heah et al. In vitro and in vivo studies of ganoderma lucidum in cancer
CN104623101A (en) Traditional Chinese medicine for treating cancer as well as preparation method and application of traditional Chinese medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant